In a 2-page paper, describe the care that Anna would require and address the questions below. 1. What risk factors does Anna have that could predispose her to the development of cancer? 2. What signs and symptoms could indicate that Anna has developed cancer? 3. Based on Anna’s risk factors and presenting problems, identify three multidimensional care strategies that you would use to provide quality care to Anna. Provide rationale to explain why you chose these strategies.

Signs and Symptoms Indicating Anna’s Development of Cancer

The signs and symptoms of cancer development in an individual can be of a wide range. Some of the signs and symptoms that Anna has been experiencing, and they are associated with cancer, may include the presence of a palpable lump in Anna’s right breast. The lump in the right breast could result from the growth of a tumor mass which eventually would lead to the development of breast cancer (Clark & Bishop, 2022). A second symptom indicating the risk of Anna developing cancer is that she is experiencing nipple pain which could be caused by the tumor obstructing the areola. Finally, Anna is experiencing tenderness, where inflammation caused by the tumor can cause tenderness and warmth in a person. In addition, she is experiencing fatigue, as she said she has been feeling like herself for the past six months and has been unusually tired. Understanding such signs and symptoms that can be an indication of developing cancer in our bodies is essential as early treatment can be conducted and eventually overcome the disease.

Multidimensional Care Strategies for Anna

Cancer management grail to cure and control the disease while minimizing the side effects of therapy. Cancer therapy includes surgery, radiation, chemotherapy, immunotherapy which includes biological response modifiers and molecularly targeted therapy, photodynamic therapy and hormonal therapy (Nandini et al., 2020). Such therapy may be helpful depending on the specific type of cancer. From the case study, Anna is already in the early stages of breast cancer diagnosis, and the following practices can be recommendable in providing high-quality care. Firstly, it would be essential to provide reliable information and clarify diagnostic measures and treatment alternatives to minimize uncertainty about her condition as she is already stressed, and she has a history of non-compliance with prescriptions given to her treatment, providing reliable information and decreasing uncertainty may help to promote her compliance and reduce the delay.  It would also be vital to promote patients’ physical and psychological well-being by adopting care procedures that prevent cancer development (Ariad et al., 2019). In Anna’s case, this would enable her to prepare for the possible results, reduce worries, and encourage her to participate in treatment actively. Lastly, it would be crucial to establish care coordination and promote social support for Anna’s case, her burden in caring for her three children could hurt her possible treatment, and as a result, encouraging social support and seeking assistance programs for comprehensive care can benefit her-centred care. such strategies are essential as they can help an individual manage and overcome complications brought by the disease.

Conclusion

Cancer is a life-threatening disease that can lead to death without interventions and early diagnosis of the disease is recommendable as it can help to minimize the complications of the disease, and even to some extent, the disease can be overcome. Based on Anna’s symptoms and risk factors, she is at risk of suffering from breast cancer, where the condition can be managed using multidimensional care. It would be essential for Anna to adhere to her healthcare provider’s recommendations in order to enhance the effective management of her condition.

 

References

Altekruse, S. F., Shiels, M. S., Modur, S. P., CROTHERS, K. A., KITAHATA, M. M., THORNE, J. E., … & ENGELS, E. A. (2018). Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS (London, England)32(4), 513.

Order this paper